Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +53.00p +4.74% 1,172.00p 1,167.00p 1,170.00p 1,196.00p 1,118.00p 1,124.00p 1,435,060 16:35:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1,579.1 170.1 53.9 22.7 2,820.39

Hikma Pharmaceuticals Share Discussion Threads

Showing 826 to 848 of 850 messages
Chat Pages: 34  33  32  31  30  29  28  27  26  25  24  23  Older
DateSubjectAuthorDiscuss
21/8/2017
18:32
FYI Hikma Pharmaceuticals was boosted by an upgrade to 'hold' from 'underperform' at Jefferies.
nortic 007
21/8/2017
16:23
So if you could wind the clock back you wouldn't have bought any. Sounds like sour grapes to me .Maybe you're the mug???
nortic 007
21/8/2017
16:09
I think not A throw of the dice .... which has attracted a few mugs R U 1 ?
buywell3
21/8/2017
14:42
Nice day 🤡✌A039;
glenkaz
21/8/2017
13:12
Time to close your shorts - if you have any
justiceforthemany
21/8/2017
13:08
Good call sir
nortic 007
21/8/2017
10:55
On Level 2
justiceforthemany
21/8/2017
10:55
A lot of buys coming in now
justiceforthemany
21/8/2017
07:17
Assuming US medication junkies carry on using the same stuff what is the increase in Revenue likely to be V 6 price rises ? Anybody done the maths
buywell3
21/8/2017
07:16
Trump will fix them rotten - Would not touch with a bargepole- OK maybe short term trade but like the wartime case of sardines "for trading not eating"
pugugly
21/8/2017
06:56
🦑 's 🤡✌A039;
glenkaz
20/8/2017
22:35
The truth is the truth sir......indeed this will be back up to 14 squid in no time but how low will it go?? I'm already in with a spread and looking to add more if it goes down.
balbains324
20/8/2017
22:26
Not sure if this is the type of publicity they need in the present hostile pharma environment.
cumnor
20/8/2017
21:16
Burnt badly...
justiceforthemany
20/8/2017
21:15
Interesting and highly significant piece of news. Shorters will get burnt here. https://www.ft.com/content/05ae5a46-8457-11e7-94e2-c5b903247afd Hikma’s US unit sharply raises prices of several drugs West-Ward increase cost of medicines by as much as 430%
justiceforthemany
20/8/2017
17:42
Come on Tottenham !!!
nortic 007
20/8/2017
17:41
Can you imagine an analyst at the races. He'd want to change his bet in the final furlong because his horse wasn't winning and the same philosophy applies to Hikma.
nortic 007
20/8/2017
17:37
My experience of analysts is they normally call the bottom. They just tow the line because if they all say the same then they won't lose their jobs. Some of my best trades have been in Anglo American, Glencore, Vodafone and Sports Direct and all of them recovered strongly after the most bearish notes you'll ever see.Don't tell us something after the event Mr HSBC, tell us before and then you might earn a morsel of respect .
nortic 007
20/8/2017
17:10
I bought in on Friday at 1136p. What I find distasteful though is the mob that puts the boot in at the first opportunity although this has given me a chance to buy into this stock at what I think is a pretty good price. I only found myself here after following GSK for a while. Could go lower, or could bounce on Monday but HSBC's latest note won't help. As no-one ever believes overly bullish broker notes, I'm sceptical of HSBC's overly bearish. I bet the Darwazah's must be really hacked off with this short attack and could well decide to take HIK private. Plus it's the silly season so I'm anticipating a good recovery by year end latest. No stop losses set so buckled in for the ride. Took a similar opportunity with PAYS when it was taken down to circa 300p with lots of negative posts and plain old scaremongering. GLA lth's
marine boy
20/8/2017
12:54
If you are not interested in this company or do not like the fundamentals then why are you here?
justiceforthemany
20/8/2017
10:36
In terms of quality, hik is in no league to gsk and azn. One is distributor of generic drug while the others are developing original new drugs that are protected by patents for many years. All intangibles are not equal. Besides, gsk and azn are also only stocks for income at the moment and gsk has not been a good performer for a long time.
riskvsreward
20/8/2017
10:00
Broker rating lower ☹️
glenkaz
20/8/2017
09:16
I'm quite new to this company gentlemen but how many does the CEO hold ? It'll be interesting to see if he adds to his holding.
nortic 007
Chat Pages: 34  33  32  31  30  29  28  27  26  25  24  23  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170821 23:53:32